Skip to main content

HOPA Abstracts

Identifying Barriers to Expanded Access Program (EAP) Patient Enrollment in the Hematology/Oncology Community
Abstract #CR12
Jahmal Williams, PharmD, RPh; Claire Groce, PharmD; Madison Henry, PharmD, RPh; Kyle Taylor, PharmD, RPh; Nik Mohan, PharmD; Joseph Barone, PharmD, FCCP, et al.
Read More
Effect of Clinically Embedded Oncology Pharmacists on Immune Checkpoint Inhibitor Treatment Outcomes
Abstract #CR13
Colton Zwart, PharmD, BCOP; Mark Wagner, PharmD, BCOP; Karen Farris, PhD; David Reyes-Gastelum; Katie Young; Emily Mackler, PharmD, BCOP
Read More
Effect of Clinically Embedded Pharmacists on the Time of Other Oncology Clinicians
Abstract #CR14
Maja Hill, PharmD; Emily Mackler, PharmD, BCOP; Maisa Nazzal, PharmD, MS; Karen Farris, PhD; Emily Johengen, PharmD, BCACP; Katie Sias, PharmD, BCOP, et al.
Read More
Effect of Embedded Clinical Pharmacists on Health Utilization Outcomes in a Large Community Oncology Practice
Abstract #CR15
Mark Wagner, PharmD, BCOP; Colton Zwart, PharmD, BCOP; Karen Farris, PhD; David Reyes-Gastelum; Katie Young; Emily Mackler, PharmD, BCOP
Read More
Improving Oral Anticancer Medication Adherence/Adverse Event Assessment Documentation
Abstract #CR16
Lisa Holle, PharmD, BCOP, FHOPA, FISOPP; Grace Morrison, BS; Andrea Moran, APRN-BC, DNP; Margaret Savage, BSN, RN; Michael K. Keng, MD
Read More
Managing Oral Anticancer Therapies in Patients With Early or Advanced HR-Positive, HER2-Negative Breast Cancer: A US-based Community Healthcare Provider Survey
Abstract #CR18
Jodi L. Taraba, PharmD, MS, BCOP; Pamela K. Ginex, EdD, MPH, RN, OCN; Qinli Lily Ma, PhD; Kelli Thoele, PhD, RN, OCN; Alexandra S. Vitko, PhD; Astra M. Liepa, PharmD, et al.
Read More
Safety and Cost Associated With Fixed-Dose Immunotherapy in Patients With Weight Extremes
Abstract #CR19
Christina Davis, PharmD, BCOP; Cali Lunowa, PharmD; Moriah Cargile
Read More
Safety and Feasibility of Short-Duration Infusion Obinutuzumab With Venetoclax in Patients With Chronic Lymphocytic Leukemia: A Prospective Observational Study
Abstract #CR20
Matthew Lei, PharmD; Uvette Lou, PharmD; Mark Sorial, PharmD; Brenna Rowen, PharmD; E. Bridget Kim, PharmD; Rana Ruchi, PharmD, et al.
Read More
Updated Biodistribution and Shedding Analysis of RP1 Oncolytic Immunotherapy From the IGNYTE Clinical Trial: Administration and Handling Implications for Oncology Pharmacists
Abstract #CR21
Christina Davis, PharmD; Caroline Robert, MD, PhD; Michael K. Wong, MD, PhD; Mark R. Middleton, MD, PhD, FRCP; Mohammed M. Milhem, MBBS; Joseph J. Sacco, PhD, FRCP, et al.
Read More
Venetoclax and Obinutuzumab in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A 3-Year Follow-Up
Abstract #CR22
Uvette Lou, PharmD, BCOP; Matthew Lei, PharmD, BCOP; Mark Sorial, PharmD, BCOP; Michelle Yu; Andrea Medrano, BS, PharmD Candidate; Jeremy S. Abramson, MD, MS, et al.
Read More
Page 2 of 12
Results 11 - 20 of 119